Please login to the form below

Not currently logged in
Email:
Password:

Dr Ian Hudson elected vice chair of CHMP

Will serve a three-year term on EMA's scientific advisory committee

MHRA CHMP Dr Ian HudsonThe EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as its vice chair for a three-year term.

Dr Hudson has been a member of the scientific advisory committee since 2004 and is currently director of the licensing division at UK medicines regulator the MHRA.

Announcing its appointment the EMA said: “Dr Hudson brings outstanding experience and expertise from a long career in regulatory medicine and drug development, particularly in the areas of anti-infectives and oncology.”

Before joining the MHRA in 2001 Dr Hudson worked in the pharmaceutical industry for 12 years, during which time he held various clinical research and development positions at SmithKline Beecham. Prior to this he worked in clinical practice as a paediatrician.

22nd October 2012

From: Research, Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics